Detalles de la búsqueda
1.
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
N Engl J Med
; 390(2): 107-117, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952132
2.
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Circulation
; 147(23): 1748-1757, 2023 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37042255
3.
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
Eur Heart J
; 44(20): 1807-1814, 2023 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038327
4.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985309
5.
Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial.
Am Heart J
; 265: 132-136, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506747
6.
Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial.
Europace
; 25(3): 845-854, 2023 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36758013
7.
Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter.
Europace
; 24(11): 1754-1762, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374766
8.
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke.
Europace
; 24(7): 1058-1064, 2022 07 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061877
9.
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
Circulation
; 141(17): 1384-1392, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32160801
10.
Reexamination of the Embolic Stroke of Undetermined Source Concept.
Stroke
; 52(8): 2715-2722, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192898
11.
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
Am Heart J
; 233: 48-58, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33296688
12.
Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future.
Europace
; 23(23 Suppl 2): ii14-ii22, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837753
13.
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Europace
; 23(10): 1539-1547, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128075
14.
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial.
Europace
; 23(1): 65-72, 2021 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249467
15.
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
Europace
; 23(3): 329-344, 2021 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555020
16.
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.
Eur Heart J
; 41(30): 2848-2859, 2020 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32385506
17.
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
Circulation
; 139(20): 2292-2300, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30773022
18.
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
N Engl J Med
; 376(17): 1627-1636, 2017 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28317415
19.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
N Engl J Med
; 377(16): 1513-1524, 2017 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844193
20.
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
Eur Heart J
; 40(19): 1553-1562, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30793734